Accessibility Menu
C-mer Medical logo

C-mer Medical(SEHK) 3309

Market CapHK$1.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-82%
5 Year-89%
1 Year-57%
1 Month-8%
HK$0.86
+2.40%
+0.02Today
C-mer Medical last closing stock price
MetricPriceDate
Last closeHKD 0.862026-09-01
C-mer Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%HKD 0.862026-08-25
1 month-8.06%HKD 0.932026-07-31
3 month-21.56%HKD 1.092026-06-03
Year to date-50.29%HKD 1.722025-12-31
1 year-57.46%HKD 2.012025-09-01
3 year-76.83%HKD 3.692023-08-31
5 year-89.04%HKD 7.802021-09-02
Since inception-82.34%HKD 4.842018-01-15

C-mer Medical Financials at a Glance

Market Cap

HK$1.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

HK$3.96B

Net Income (TTM)

-HK$15.54M

EPS (TTM)

HK$0.08

P/E Ratio

10.13

Dividend

HK$0.02

Beta (Volatility)

-0.00 (Low)

Price

HK$0.86

Volume

168,000

Open

HK$0.84

Previous Close

HK$0.84

Daily Range

HK$0.84 - HK$0.86

52-Week Range

HK$0.83 - HK$2.09

Estimated Earnings Date

Mar 30, 2027

3309 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About C-mer Medical

C-MER Medical Holdings Limited specializes in offering medical treatments and therapeutic services for various eye conditions. Established in 2016, the company operates primarily in ophthalmological services and the retail of vision-enhancing products.

Products and Services
  • Ophthalmological services for eye conditions
  • Retail of vision-enhancing products
  • Comprehensive eye care solutions
Growth Outlook
  • Revenue increased to HKD 1.02 billion in Q2 2026
  • Gross profit margin improved to 31.6% in recent quarters
  • Strong demand for eye care services supports future growth
Financial Highlights
  • Net income of HKD 50.02 million reported in Q2 2026
  • TTM revenue of HKD 3.93 billion reflects consistent growth
  • Dividend yield of 3.49% indicates shareholder returns
C-MER Medical Holdings Limited has established itself as a key player in the healthcare sector, particularly in eye care. The company's focus on both medical treatments and retail products positions it well to capitalize on the growing demand for eye health services. Recent financial performance shows a positive trend, with significant revenue growth and improved profit margins. The company’s ability to maintain a strong gross profit margin and generate consistent net income highlights its operational efficiency and market relevance. With a solid dividend yield, C-MER Medical Holdings Limited presents an attractive opportunity for investors interested in the healthcare industry.
AI Generated • Aug 30, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

2,200

CEO

Xiao Ting Li

Website

www.cmereye.com

Headquarters

Hong Kong, HK

3309 Financials

Key Financial Metrics (TTM)

Gross Margin

31.24%

Operating Margin

8.57%

Net Income Margin

4.96%

Return on Equity

5.57%

Return on Capital

7.61%

Return on Assets

3.51%

Earnings Yield

9.87%

Dividend Yield

2.34%

Payout Ratio

0.00%

Stock Overview

Market Cap

HK$1.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.19B

Volume

168.00K

Avg. Volume

363.83K

Financials (TTM)

Gross Profit

HK$1.23B

Operating Income

HK$115.34M

EBITDA

HK$505.28M

Operating Cash Flow

HK$576.96M

Capital Expenditure

-HK$236.14M

Free Cash Flow

HK$340.82M

Cash & ST Invst.

HK$563.37M

Total Debt

HK$433.61M

C-mer Medical Performance Analysis

C-mer Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31HKD 1,731,903,00055.7%
20232023-12-31HKD 1,923,964,00011.1%
20242024-12-31HKD 1,913,162,000-0.6%
20252025-12-31HKD 1,946,712,0001.8%
C-mer Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-317.4%
Q22025-06-30-4.7%
Q42025-12-316.1%
Q22026-06-302.2%
C-mer Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31HKD -0.02N/A
20232023-12-31HKD 0.05N/A
20242024-12-31HKD -0.11N/A
20252025-12-31HKD 0.08N/A
C-mer Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-624.2%
Q22025-06-30131.6%
Q42025-12-312.4%
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

HK$1.02B

+11.0%

Gross Profit

HK$323.36M

+11.8%

Gross Margin

31.56%

N/A

Market Cap

HK$1.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

HK$462.50K

N/A

Employees

2,200

N/A

Net Income

HK$50.02M

+62.6%

EBITDA

HK$198.32M

+82.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

HK$563.37M

+10.0%

Total Debt

HK$433.61M

+8.1%

Accounts Receivable

HK$60.72M

+14.7%

Inventory

HK$55.38M

+14.4%

Long Term Debt

HK$260.93M

-10.0%

Short Term Debt

HK$172.68M

+55.2%

Return on Assets

3.51%

N/A

Return on Invested Capital

7.45%

N/A

Free Cash Flow

HK$145.77M

+53.6%

Operating Cash Flow

HK$178.91M

+7.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About 3309

What is the current price of C-mer Medical?

C-mer Medical is trading at HK$0.86 per share.

What is the 52-week range for C-mer Medical?

Over the past 52 weeks, C-mer Medical has traded between HK$0.83 and HK$2.09.

How much debt does C-mer Medical have?

As of the most recent reporting period, C-mer Medical reported total debt of HK$426.78M.

How much cash does C-mer Medical have on hand?

C-mer Medical reported HK$347.87M in cash and cash equivalents in its most recent financial results.

What is C-mer Medical’s dividend yield?

C-mer Medical currently has a dividend yield of 2.34%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services